Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Multiple Myeloma × bosutinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Chronic-Phase 1 Blast Crisis 1

Interventions

Dexamethasone 75 Lenalidomide 47 daratumumab 43 Bortezomib 28 pomalidomide 26 Cyclophosphamide 26 carfilzomib 22 Calcium Dobesilate 20 talquetamab 17 fludarabine 17 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 iberdomide 14 Biopsy 14 isatuximab 13 belantamab mafodotin 12 selinexor 10 elotuzumab 9 dexamethasone acetate 9 dexamethasone 21-phosphate 8 auricularum 8 Melphalan 8 venetoclax 6 X-Rays 6 tocilizumab 5 Blood Specimen Collection 5 ruxolitinib 4 pegylated granulocyte colony-stimulating factor 4 ixazomib 4 idecabtagene vicleucel 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297606 2026-03-04

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡